Diagnostic and therapeutic considerations on inherited platelet disorders in neonates and children.

Schlegel N, Bardet V, Kenet G, Muntean W, Zieger B, Nowak-Göttl U, Working Group on Standardisation in Perinatal and Pediatric Hemostasis

Forschungsartikel (Zeitschrift)

Zusammenfassung

Inherited disorders of platelets constitute a group of rare diseases that give rise to bleeding syndromes of variety severity, with more severe cases being first diagnosed during infancy and childhood. To appropriate diagnose a platelet function disorder during early childhood the knowledge of the physiological characteristics of platelets in the paediatric population is mandatory. Apart from thrombocytopenia which is quite common in neonates and children the present overview is aimed to focus on inherited platelet function disorders. Furthermore, knowledge on platelet maturation and reference values according to age are given, and a diagnostic strategy specifically adapted to a pediatric population is presented on the bases of plasmatic and molecular laboratory methodologies. Finally, therapeutic approaches are briefly summarized (antifibrinolytic agents, Desmopressin, HLA-matched platelets, recombinant factor VIIa).

Details zur Publikation

FachzeitschriftKlinische Pädiatrie
Jahrgang / Bandnr. / Volume222
Ausgabe / Heftnr. / Issue3
Seitenbereich209-214
StatusVeröffentlicht
Veröffentlichungsjahr2010
Sprache, in der die Publikation verfasst istEnglisch
DOI10.1055/s-0030-1249065
StichwörterInfant Newborn; von Willebrand Diseases; Factor VIIa; Platelet Transfusion; Blood Platelet Disorders; von Willebrand Factor; Antifibrinolytic Agents; Recombinant Proteins; Platelet Function Tests; Myosin Heavy Chains; DNA Mutational Analysis; Child; Humans; Molecular Motor Proteins; Thrombocytopenia; Partial Thromboplastin Time; Platelet Count; Hemorrhagic Disorders; Deamino Arginine Vasopressin; Syndrome; Infant; Diagnosis Differential; Infant Newborn; von Willebrand Diseases; Factor VIIa; Platelet Transfusion; Blood Platelet Disorders; von Willebrand Factor; Antifibrinolytic Agents; Recombinant Proteins; Platelet Function Tests; Myosin Heavy Chains; DNA Mutational Analysis; Child; Humans; Molecular Motor Proteins; Thrombocytopenia; Partial Thromboplastin Time; Platelet Count; Hemorrhagic Disorders; Deamino Arginine Vasopressin; Syndrome; Infant; Diagnosis Differential

Autor*innen der Universität Münster

Nowak-Göttl, Ulrike
Klinik für Kinder- und Jugendmedizin - Pädiatrische Hämatologie und Onkologie - (UKM PHO)